Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHB1801470	洛匹那韦/利托那韦口服溶液	lopinavir;ritonavir	Oral solution	Chemical Drugs	Supplementary Application	2018-12-13	AbbVie Inc	Abbvie Inc	Filed	2018-12-19	view
JYHB1900573	洛匹那韦/利托那韦口服溶液	lopinavir;ritonavir	Oral solution	Chemical Drugs	Supplementary Application	2019-05-27	AbbVie Inc	Abbvie Inc	Certificate Issued	2021-02-25	view
JYHB2000636	洛匹那韦/利托那韦口服溶液	lopinavir;ritonavir	Oral solution	Chemical Drugs	Supplementary Application	2020-05-27	AbbVie Inc	Abbvie Inc	Filed	2020-06-09	view
JYHB2001571	洛匹那韦/利托那韦口服溶液	lopinavir;ritonavir	Oral solution	Chemical Drugs	Supplementary Application	2020-08-25	AbbVie Inc	Abbvie Inc	Certificate Issued	2021-02-25	view
JYHZ1700300	洛匹那韦/利托那韦口服溶液	lopinavir;ritonavir	Oral solution	Chemical Drugs	License Renew	2018-01-19	AbbVie Inc	Abbvie Inc	Certificate Issued	2018-08-14	view
JYHZ2300011	洛匹那韦/利托那韦口服溶液	lopinavir;ritonavir	Oral solution	Chemical Drugs	License Renew	2023-01-06		AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Inc			view